| DRD2 |
DRD2: D(2) dopamine receptor |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
GPR101 |
GPR101: Probable G-protein coupled receptor 101 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
EDG2 |
EDG2, LPA1: Lysophosphatidic acid receptor Edg-2 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
OR1D2 |
OR1D2, OLFR1: Olfactory receptor 1D2 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
EDNRA |
EDNRA, ETA, ETRA: Endothelin-1 receptor precursor |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CNR1 |
CNR1, CNR: Cannabinoid receptor 1 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
0.745 |
Evidence |
|
| GFAP |
GFAP: Glial fibrillary acidic protein |
CAPN11 |
CAPN11: Calpain-11 |
0.745 |
Evidence |
|
| HOXD8 |
HOXD8, HOX4E: Homeobox protein Hox-D8 |
TFEB |
TFEB: Transcription factor EB |
0.745 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
C1QTNF5 |
C1QTNF5, CTRP5, UNQ303/PRO344: Complement C1q tumor necrosis factor-related prot |
0.745 |
Evidence |
|
| ERG |
ERG: Transcriptional regulator ERG |
HIST2H2AA |
HIST2H2AA3, H2AFO, HIST2H2AA: Histone H2A type 2-A |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
EDNRA |
EDNRA, ETA, ETRA: Endothelin-1 receptor precursor |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
CNR1 |
CNR1, CNR: Cannabinoid receptor 1 |
0.745 |
Evidence |
|
| CHRM1 |
CHRM1: Muscarinic acetylcholine receptor M1 |
DRD2 |
DRD2: D(2) dopamine receptor |
0.745 |
Evidence |
|